Global Blood Glucose Monitoring Devices Market - Focused Insights 2024-2029

THE GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET WAS VALUED AT USD 25.62 BILLION IN 2023 AND IS EXPECTED TO REACH USD 52.46 BILLION BY 2029, GROWING AT A CAGR OF 12.69% DURING THE FORECAST PERIOD.

Global Blood Glucose Monitoring Devices Market Size Report

The Blood Glucose Monitoring Devices Market Size by Product Type, by Conventional Blood Glucose Monitoring (BGM) Devices, by Continuous Glucose Monitoring (CGM) Devices, by Usage Distribution Channel, and by End-Users

160 pages

16 tables

38 charts

5 region

19 countries

40 company

7 segments

Purchase Options

$2990
$3500
$4500
$2000

Global Blood Glucose Monitoring Devices Market - Focused Insights 2024-2029

THE GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET WAS VALUED AT USD 25.62 BILLION IN 2023 AND IS EXPECTED TO REACH USD 52.46 BILLION BY 2029, GROWING AT A CAGR OF 12.69% DURING THE FORECAST PERIOD.

The Blood Glucose Monitoring Devices Market Size, Share & Trend Analysis Report By

  1. Product Type: Conventional Blood Glucose Monitoring Devices and Continuous Glucose Monitoring (CGM) Devices
  2. Conventional Blood Glucose Monitoring Devices: Test Strips, Meter & Software, and Lancet & Lancing Devices
  3. Continuous Glucose Monitoring (CGM) Devices: Sensors and Reusable Hardware
  4. Usage: Personal BGM Devices and Professional BGM Devices
  5. Distribution Channel: Offline and Online
  6. End-Users: Individuals, Hospitals & Clinics, and Other End-users
  7. Geography: North America, Europe, APAC, Latin America, and Middle East & Africa

Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2024–2029.

Customize this Report

This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize

BLOOD GLUCOSE MONITORING DEVICES MARKET REPORT SCOPE

REPORT ATTRIBUTEDETAILS
Market Size (2029)USD 52.46 Billion
Market Size (2023)USD 25.62 Billion
CAGR (2023-2029)12.69%
HISTORIC YEAR2020-2022
BASE YEAR2023
FORECAST YEAR2024-2029
MARKET SEGMENTS BYProduct Type, Conventional Blood Glucose Monitoring Devices, Continuous Glucose Monitoring (CGM) Devices, Usage, Distribution Channel, End-Users, and Geography
GEOGRAPHIC ANALYSISNorth America, Europe, APAC, Latin America, and Middle East & Africa
KEY PLAYERSF. Hoffmann-La Roche, Abbott, Dexcom, Medtronic, Ascensia Diabetes Care Holdings AG, and LifeScan IP Holdings
Interested in this Report?

GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET SIZE

The global blood glucose monitoring devices market was valued at USD 25.62 billion in 2023 and is expected to reach USD 52.46 billion by 2029, growing at a robust CAGR of 12.69% during the forecast period. This substantial growth is primarily driven by the escalating global burden of diabetes, rising obesity rates, increased awareness of health and wellness, and a growing elderly population vulnerable to chronic conditions. Technological advancements and the increasing adoption of self-care practices are significantly fueling the self-monitoring blood glucose device market as patients take a more proactive role in managing their health.

Blood glucose monitoring devices (BGMs), including conventional blood glucose monitors and continuous glucose monitors (CGMs), play a critical role in diabetes management. These tools provide real-time or near-real-time insights into blood glucose levels, allowing individuals and healthcare providers to personalize treatment strategies and avoid complications.

BLOOD GLUCOSE MONITORING DEVICES MARKET TRENDS & DRIVERS

Continuous Innovation in Glucose Monitoring Technology

The blood glucose monitoring market is undergoing a transformative shift with the introduction of next-generation technologies. Among these, optical sensing and non-invasive glucose monitoring methods are gaining traction. These solutions aim to eliminate the discomfort of finger pricking and improve patient compliance. The development of sensors capable of detecting glucose using light-based measurements has created new opportunities, making monitoring more seamless and user-friendly.

Rising Popularity of Flash Glucose Monitoring (FGM)

Flash glucose monitoring, a subset of CGM, is emerging as a pivotal trend. Unlike traditional methods, FGM systems offer users the convenience of checking glucose levels at any time without constant calibration. Their ability to provide 24-hour data with minimal intrusion is positioning them as a preferred choice, especially among younger, tech-savvy diabetic patients. Clinical evidence supports FGM’s ability to reduce hyperglycemic and hypoglycemic events, further accelerating its adoption.

Government and Public Health Initiatives Supporting Growth

Governments worldwide are implementing programs to combat the rising tide of diabetes and improve disease management. From the WHO's Global Diabetes Compact to national campaigns such as India’s NPCDCS, public health authorities are promoting early diagnosis, prevention, and the widespread use of self-monitoring blood glucose devices. These initiatives enhance access to BGM technologies, particularly in low-resource settings, driving both awareness and demand.

BLOOD GLUCOSE MONITORING DEVICES MARKET SEGMENT INSIGHTS

By Product Type

The global blood glucose monitoring devices market are segmented into conventional blood glucose monitoring devices (including test strips, lancets, and meters) and continuous glucose monitoring (CGM) devices (including sensors and reusable hardware). Despite the growing popularity of CGMs, conventional BGMs continue to dominate with the largest market share of 70%, due to their cost-effectiveness, user familiarity, and accessibility—especially in low- and middle-income countries. The affordability and simplicity of conventional BGMs make them indispensable in the glucose monitoring devices market.

By Usage

Personal BGM devices represent the fastest-growing segment, as individuals increasingly adopt self-monitoring routines. Particularly among Type 1 diabetics, frequent monitoring is essential for insulin dosage management. The proliferation of smartphone-compatible meters and apps is also contributing to the growth of self-monitoring blood glucose device market, supporting patient empowerment and reducing dependency on clinical visits.

By Distribution Channel

Offline channels, including hospital pharmacies, independent drug stores, and wellness retailers, continue to lead distribution. These outlets serve as the first point of access for diabetes patients across developed and emerging markets. However, the rise of e-commerce and online pharmacies is expected to gain momentum as digital health ecosystems expand.

By End-user

Individual users dominate the end-user segment, driven by the trend toward home-based health management. In many regions, limited healthcare infrastructure and high diagnostic costs make self-monitoring the most viable option. Reimbursement support and insurance coverage in developed countries further encourage personal adoption of BGM devices.

GEOGRAPHICAL ANALYSIS

North America holds the largest blood glucose monitoring devices market share, accounting for over 44% in 2023. The region benefits from strong healthcare infrastructure, high diabetes prevalence, and widespread insurance coverage for glucose monitoring technologies. Additionally, early adoption of digital health tools and continuous product innovation contribute to North America's market dominance.

VENDOR LANDSCAPE

The global glucose monitoring devices market is highly fragmented yet dynamic, with leading companies such as Abbott, Medtronic, Dexcom, F. Hoffmann-La Roche, and LifeScan spearheading innovation. These firms invest heavily in R&D to refine sensor technology, enhance user interfaces, and expand non-invasive monitoring capabilities. Startups and smaller firms are also entering the space with disruptive technologies, especially in the wearable and AI-integrated device segments, increasing competition and diversification within the market.

Recent Vendor Activities

  1. In 2024, MTD Group acquired the pen needle and blood glucose monitoring systems of Ypsomed, as well as announced significant investment for its European product sites.
  2. In 2023, Abbott acquired Bigfoot Biomedical- one of the leading smart insulin management system manufacturing companies. This transaction helped Abbott increase its presence in diabetes care by strengthening its FreeStyle Libre CGM Technology. 
  3. In 2023, Medtronic entered into a set of definitive agreement to acquire EoFlow Co. Ltd., a pioneer in insulin delivery devices. Medtronic’s meal detection technology algorithm and next-generation CGM are expected to expand the company’s ability to deliver diabetes care solutions.
  4. In 2022, Abbott collaborated with Sugar.fit, BeatO, Zyla Health, 1MG, PharmEasy, GOQii, Helthifyme, and Fitterfly to expand access to diabetes management care. Through this collaboration, Abbott aims to offer glucose monitoring solutions to around 8 billion people with diabetes. More than 6.5 billion people receive these solutions through PharmEasy and 1MG.
  5. In 2022, embecta and Intuity Medical made a commercial collaboration to promote POGO -Automatic Blood Glucose Monitoring systems to medical professionals across the US.
  6. In 2020, One Drop, a diabetes management company, acquired assets, IP, and certain Staff of Sano Intelligence who manufactured non-invasive connected CGM Patch.

Product Launched & Development

  1. In Jun 2024, Prevounce Health launched a technologically advanced and cellular-connected blood glucose meter for remote patient monitoring. It is a rigorously tested and FDA-approved device widely available in the US and global markets.
  2. In Jun 2024, the US FDA approved Abbott’s two over-the-counter continuous glucose monitoring devices, Libre Rio and Lingo, used by more than 6 million globally.
  3. In May 2024, Smart Meter launched an iGlucose Plus glucose monitoring device globally. It is a handheld device connected to a smartphone and Wi-Fi systems.
  4. In Feb 2024, Dexcom launched Dexcom ONE+, a real-time and customized glucose monitoring device that can be worn in three different body locations. Furthermore, it has a water-resistant sensor that enhances its brand image.
  5. In Feb 2024, Know Labs launched KnowU –a wearable and non-invasive continuous glucose monitoring device with onboard computing power and machine learning technologies.
  6. In Jan 2022, Roche launched a smart, handheld, and point-of-care blood glucose monitor device for the hospital’s bedside use.

SNAPSHOT

The global blood glucose monitoring devices market size is expected to grow at a CAGR of approximately 12.69% from 2023 to 2029.

Base Year: 2023

Forecast Year: 2024-2029

The report considers the present scenario of the global blood glucose monitoring devices and its market dynamics for 2024−2029. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the market.

VENDORS LIST

Key Vendors

  1. F. Hoffmann-La Roche
  2. Business Overview
  3. Product Offerings
  4. Abbott
  5. Dexcom
  6. Medtronic
  7. Ascensia Diabetes Care Holdings AG
  8. LifeScan IP Holdings

Other Prominent Vendors

  1. Arkray
  2. Business Overview
  3. Product Offerings
  4. ApexBio
  5. ACON Laboratories, Inc.
  6. AgaMatrix
  7. Alliance International
  8. Andon Health
  9. Bionime
  10. Beurer
  11. Bioptik
  12. BioTelemetry
  13. BioTest Medical
  14. BTNX
  15. DarioHealth
  16. EASYMAX
  17. ForaCare
  18. Hannox International
  19. Integrity Applications
  20. i-SENS
  21. MED TRUST
  22. Medisana
  23. Nova Biomedical
  24. Omnis Health
  25. Nemaura
  26. OK Biotech
  27. OSANG Healthcare
  28. Philosys
  29. Sanofi
  30. Taidoc Technology
  31. Terumo Corporation
  32. Trividia Health
  33. Rossmax International
  34. Ypsomed
  35. 77 Electronika Kft
  36. Menarini Diagnostics

SEGMENTATION & FORECAST

  1. By Product Type
  2. Conventional Blood Glucose Monitoring Devices
  3. Continuous Glucose Monitoring (CGM) Devices
  4. By Conventional Blood Glucose Monitoring Devices
  5. Test Strips
  6. Meter & Software
  7. Lancet & Lancing Devices
  8. By Continuous Glucose Monitoring (CGM) Devices
  9. Sensors
  10. Reusable Hardware
  11. By Usage
  12. Personal BGM Devices
  13. Professional BGM Devices
  14. By Distribution Channel
  15. Offline
  16. Online
  17. By End-Users
  18. Individuals
  19. Hospitals & Clinics
  20. Other End-users
  21. By Geography
  22. North America
  23. The U.S.
  24. Canada
  25. Europe
  26. Germany
  27. The U.K.
  28. France
  29. Italy
  30. Spain
  31. APAC
  32. Japan
  33. China
  34. India
  35. Australia
  36. South Korea
  37. Latin America
  38. Brazil
  39. Mexico
  40. Columbia
  41. Argentina
  42. Middle East & Africa
  43. Turkey
  44. South Africa
  45. Saudi Arabia

BLOOD GLUCOSE MONITORING DEVICES MARKET FAQs

How big is the global blood glucose monitoring devices market?

The global blood glucose monitoring devices market was valued at USD 25.62 billion in 2023 and is expected to reach USD 52.46 billion by 2029.

What is the growth rate of the global blood glucose monitoring devices market?

The global blood glucose monitoring devices market is expected to grow at a CAGR of 12.69% during the forecast period.

Which region dominates the global blood glucose monitoring devices market?

North America dominates the global blood glucose monitoring devices market.

Who are the major players in the global blood glucose monitoring devices market?

F. Hoffmann-La Roche, Abbott, Dexcom, Medtronic, Ascensia Diabetes Care Holdings AG, and LifeScan IP Holdings are the major players in the global blood glucose monitoring devices market.

Exhibit 1: Projected Revenues of Blood Glucose Monitoring Devices Market in Global (2020 – 2029; $ BN)

Exhibit 2: Market Size & Forecast – Conventional BGM Devices (2020 – 2029; $ BN)

Exhibit 3: Market Size & Forecast – Test Strips (2020 – 2029; $ BN)

Exhibit 4: Market Size & Forecast – Meter & Software (2020 – 2029; $ BN)

Exhibit 5: Market Size & Forecast – Lancet & Lancing Devices (2020 – 2029; $ BN)

Exhibit 6: Market Size & Forecast – Continuous Glucose Monitoring Devices (2020 – 2029; $ BN)

Exhibit 7: Market Size & Forecast – Sensors (2020 – 2029; $ BN)

Exhibit 8: Market Size & Forecast – Reusable Hardware (2020 – 2029; $ BN)

Exhibit 9: Market Size & Forecast – Personal BGM Devices (2020 – 2029; $ BN)

Exhibit 10: Market Size & Forecast – Professional BGM Devices (2020 – 2029; $ BN)

Exhibit 11: Market Size & Forecast – Offline Stores (2020 – 2029; $ BN)

Exhibit 12: Market Size & Forecast – Online Stores (2020 – 2029; $ BN)

Exhibit 13: Market Size & Forecast – Individuals (2020 – 2029; $ BN)

Exhibit 14: Market Size & Forecast – Hospitals & Clinics (2020 – 2029; $ BN)

Exhibit 15: Market Size & Forecast – Other End-user (2020 – 2029; $ BN)

Exhibit 16: Projected Revenues of Blood Glucose Monitoring Devices Market in N. America (2020 – 2029; $ BN)

Exhibit 17: Projected Revenues of Blood Glucose Monitoring Devices Market in the US (2020 – 2029; $ BN)

Exhibit 18: Projected Revenues of Blood Glucose Monitoring Devices Market in Canada (2020 – 2029; $ BN)

Exhibit 19: Projected Revenues of Blood Glucose Monitoring Devices Market in Europe (2020 – 2029; $ BN)

Exhibit 20: Projected Revenues of Blood Glucose Monitoring Devices Market in Germany (2020 – 2029; $ BN)

Exhibit 21: Projected Revenues of Blood Glucose Monitoring Devices Market in France (2020 – 2029; $ BN)

Exhibit 22: Projected Revenues of Blood Glucose Monitoring Devices Market in the UK (2020 – 2029; $ BN)

Exhibit 23: Projected Revenues of Blood Glucose Monitoring Devices Market in Italy (2020 – 2029; $ BN)

Exhibit 24: Projected Revenues of Blood Glucose Monitoring Devices Market in Spain (2020 – 2029; $ BN)

Exhibit 25: Projected Revenues of Blood Glucose Monitoring Devices Market in APAC (2020 – 2029; $ BN)

Exhibit 26: Projected Revenues of Blood Glucose Monitoring Devices Market in China (2020 – 2029; $ BN)

Exhibit 27: Projected Revenues of Blood Glucose Monitoring Devices Market in Japan (2020 – 2029; $ BN)

Exhibit 28: Projected Revenues of Blood Glucose Monitoring Devices Market in India (2020 – 2029; $ BN)

Exhibit 29: Projected Revenues of Blood Glucose Monitoring Devices Market in South Korea (2020 – 2029; $ BN)

Exhibit 30: Projected Revenues of Blood Glucose Monitoring Devices Market in Australia (2020 – 2029; $ BN)

Exhibit 31: Projected Revenues of Blood Glucose Monitoring Devices Market in L. America (2020 – 2029; $ BN)

Exhibit 32: Projected Revenues of Blood Glucose Monitoring Devices Market in Brazil (2020 – 2029; $ BN)

Exhibit 33: Projected Revenues of Blood Glucose Monitoring Devices Market in Mexico (2020 – 2029; $ BN)

Exhibit 34: Projected Revenues of Blood Glucose Monitoring Devices Market in Colombia (2020 – 2029; $ BN)

Exhibit 35: Projected Revenues of Blood Glucose Monitoring Devices Market in Argentina (2020 – 2029; $ BN)

Exhibit 36: Projected Revenues of Blood Glucose Monitoring Devices Market in MEA (2020 – 2029; $ BN)

Exhibit 37: Projected Revenues of Blood Glucose Monitoring Devices Market in Turkey (2020 – 2029; $ BN)

Exhibit 38: Projected Revenues of Blood Glucose Monitoring Devices Market in South Africa 2020 – 2029; $ BN)

Exhibit 39: Projected Revenues of Blood Glucose Monitoring Devices Market in Saudi Arabia (2020 – 2029; $ BN)


Tables

Table 1: Estimated & Projected Revenues of Blood Glucose Monitoring Devices in Global (2020 – 2029; $ Bn)

Table 2: Market Size & Forecast Blood Glucose Monitoring Devices Market by Product Type (2020 – 2029; $ Bn)

Table 3: Market Size & Forecast Blood Glucose Monitoring Devices Market by Product Type (2020 – 2029; %)

Table 4: Market Size & Forecast Conventional BGM Devices Market by Product Type (2020 – 2029; $ Bn)

Table 5: Market Size & Forecast Conventional BGM Devices Market by Product Type (2020 – 2029; %)

Table 6: Market Size & Forecast CGM Devices Market by Product Type (2020 – 2029; $ Bn)

Table 7: Market Size & Forecast CGM Devices Market by Product Type (2020 – 2029; $ %)

Table 8: Market Size & Forecast Blood Glucose Monitoring Devices Market by Usage (2020 – 2029; $ Bn)

Table 9: Market Size & Forecast Blood Glucose Monitoring Devices Market by Usage (2020 – 2029; %)

Table 10: Market Size & Forecast Blood Glucose Monitoring Devices Market by Dist. Channels (2020 – 2029; $ Bn)

Table 11: Market Size & Forecast Blood Glucose Monitoring Devices Market by Dist. Channels (2020 – 2029; %)

Table 12: Market Size & Forecast Blood Glucose Monitoring Devices Market by End-user (2020 – 2029; $ Bn)

Table 13: Market Size & Forecast Blood Glucose Monitoring Devices Market by End-user (2020 – 2029; %)

Table 14: Market Size & Forecast Blood Glucose Monitoring Devices Market by Geography(2020 – 2029; $ Bn)

Table 15: Market Size & Forecast Blood Glucose Monitoring Devices Market by Geography(2020 – 2029; %)

CHAPTER – 1: Blood Glucose Monitoring Devices Market Overview

  1. Executive Summary
  2. Key Findings


CHAPTER – 2: Blood Glucose Monitoring Devices Market Market

  1. GLOBAL: Projected Revenue of Blood Glucose Monitoring Devices Market (2020-2029; $ Billions)


CHAPTER – 3: Blood Glucose Monitoring Devices Market Prospects & Opportunities

  1. Blood Glucose Monitoring Devices Market Opportunities & Trends
  2. Blood Glucose Monitoring Devices Market Drivers
  3. Blood Glucose Monitoring Devices Market Constraints


CHAPTER – 4: Blood Glucose Monitoring Devices Market Segmentation Data

  1. GLOBAL: Projected Revenue by Product Type (2020-2029; $ Billions)
  2. Conventional Blood Glucose Monitoring Devices
  3. Test Strips
  4. Meter & Software
  5. Lancet & Lancing Devices
  6. Continuous Glucose Monitoring (CGM) Devices
  7. Sensors
  8. Reusable Hardware


  1. GLOBAL: Projected Revenue by Usage (2020-2029; $ Billions)
  2. Personal BGM Devices
  3. Professional BGM Devices


  1. GLOBAL: Projected Revenue by Distribution Channels (2020-2029; $ Billions)
  2. Offline Stores
  3. Online Stores


  1. GLOBAL: Projected Revenue by End-user (2020-2029; $ Billions)
  2. Individuals
  3. Hospitals & Clinics
  4. Other End-user


CHAPTER – 5: Key Regions Overview

  1. North America: Projected Revenue of Blood Glucose Monitoring Devices Market (2020-2029; $ Billions)
  2. Projected Revenue of Blood Glucose Monitoring Devices Market in the US
  3. Projected Revenue of Blood Glucose Monitoring Devices Market in Canada
  4. Europe: Projected Revenue of Blood Glucose Monitoring Devices (2020-2029; $ Billions)
  5. Projected Revenue of Blood Glucose Monitoring Devices Market in Germany
  6. Projected Revenue of Blood Glucose Monitoring Devices Market in France
  7. Projected Revenue of Blood Glucose Monitoring Devices Market in the UK
  8. Projected Revenue of Blood Glucose Monitoring Devices Market in Italy
  9. Projected Revenue of Blood Glucose Monitoring Devices Market in Spain
  10. APAC: Projected Revenue of Blood Glucose Monitoring Devices Market (2020-2029; $ Billions)
  11. Projected Revenue of Blood Glucose Monitoring Devices Market in China
  12. Projected Revenue of Blood Glucose Monitoring Devices Market in Japan
  13. Projected Revenue of Blood Glucose Monitoring Devices Market in India
  14. Projected Revenue of Blood Glucose Monitoring Devices Market in South Korea
  15. Projected Revenue of Blood Glucose Monitoring Devices Market in Australia
  16. Latin America: Projected Revenue of Blood Glucose Monitoring Devices Market (2020-2029; $ Billions)
  17. Projected Revenue of Blood Glucose Monitoring Devices Market in Brazil
  18. Projected Revenue of Blood Glucose Monitoring Devices Market in Mexico
  19. Projected Revenue of Blood Glucose Monitoring Devices Market in Colombia
  20. Projected Revenue of Blood Glucose Monitoring Devices Market in Argentina
  21. Middle East & Africa: Projected Revenue of Blood Glucose Monitoring Devices Market (2020-2029; $ Billions)
  22. Projected Revenue of Blood Glucose Monitoring Devices Market in Turkey
  23. Projected Revenue of Blood Glucose Monitoring Devices Market in South Africa
  24. Projected Revenue of Blood Glucose Monitoring Devices Market in Saudi Arabia


CHAPTER – 6:Blood Glucose Monitoring Devices Market Industry Overview

  1. Blood Glucose Monitoring Devices Market – Competitive Landscape
  2. Blood Glucose Monitoring Devices Market– Key Vendor Profiles
  3. Blood Glucose Monitoring Devices Market– Other Prominent Vendors
  4. Blood Glucose Monitoring Devices Market – Key Strategic Recommendations


CHAPTER – 7: Appendix

  1. Research Methodology
  2. Abbreviations
  3. About Arizton

Select a license type that suits your business needs

Single User Licence

$2990.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email

5 User Licence

$3500.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge

Corporate Licence

$4500.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge

Datasheet Licence

$2000.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Frequently Asked Questions

How big is the global blood glucose monitoring devices market?

The global blood glucose monitoring devices market was valued at USD 25.62 billion in 2023 and is expected to reach USD 52.46 billion by 2029.

What is the growth rate of the global blood glucose monitoring devices market?

The global blood glucose monitoring devices market is expected to grow at a CAGR of 12.69% during the forecast period.

Which region dominates the global blood glucose monitoring devices market?

North America dominates the global blood glucose monitoring devices market.

Who are the major players in the global blood glucose monitoring devices market?

F. Hoffmann-La Roche, Abbott, Dexcom, Medtronic, Ascensia Diabetes Care Holdings AG, and LifeScan IP Holdings are the major players in the global blood glucose monitoring devices market.